JANSSEN BIOTECH, INC. v. CELLTRION HEALTHCARE CO., LTD , No. 18-2321 (Fed. Cir. 2020)

Annotate this Case

Download PDF

Case: 18-2321 Document: 81 Page: 1 Filed: 03/05/2020 NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ JANSSEN BIOTECH, INC., Plaintiff-Appellant v. CELLTRION HEALTHCARE CO., LTD., CELLTRION, INC., HOSPIRA, INC., Defendants-Cross-Appellants ______________________ 2018-2321, 2018-2350 ______________________ Appeals from the United States District Court for the District of Massachusetts in No. 1:17-cv-11008-MLW, Chief Judge Mark L. Wolf. ______________________ JUDGMENT ______________________ GREGORY DISKANT, Patterson Belknap Webb & Tyler LLP, New York, NY, argued for plaintiff-appellant. Also represented by ANDREW D. COHEN, ARON RUSSELL FISCHER, EUGENE M. GELERNTER. JAMES F. HURST, Kirkland & Ellis LLP, Chicago, IL, argued for defendants-cross-appellants. Also represented by BRYAN SCOTT HALES; WILLIAM H. BURGESS, JOHN C. O'QUINN, Washington, DC. Case: 18-2321 Document: 81 Page: 2 Filed: 03/05/2020 ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (WALLACH, TARANTO, and STOLL, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT March 5, 2020 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.